The healthcare and pharmaceutical market research industry is the worlds biggest, developing, and most attention-seeking business. This industry has gone through the most measure of changes. We at Aarkstore provide our customers with the market research understanding of every single interruption happening currently or forecasted. As per our information and examination, the pharmaceutical Read More>>
COVID-19 Outbreak-Global Eye Infection Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 126
The Eye Infection Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally,....
COVID-19 Outbreak-Global Tuberculosis Diagnosis and Treatment Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 103
The Tuberculosis Diagnosis and Treatment market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak....
COVID-19 Outbreak-Global Biotech, Pharma and Health Care Automation Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 106
The Biotech, Pharma and Health Care Automation market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under....
COVID-19 Outbreak-Global Lenalidomide Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 111
Lenalidomide (trade name Revlimid) is a derivative of thalidomide approved by FDA in 2005.It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic....
COVID-19 Outbreak-Global Fabrazyme-Drug Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 115
Fabrazyme (agalsidase beta) is a man-made form of the naturally-occurring alpha-galactosidase A enzyme. A deficiency of this enzyme is called Fabry disease. Agalsidase beta reduces deposits of globotriaosylceramide (GL-3) in....